Fast Five: Medtronic has a Class I recall of some ICDs, Endologix completes first procedures using Detour system
19 Jul 2023
Executive Change
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, July 19, 2023.
Fast Five by MassDevice · Medtronic has a Class I recall, Endologix completes first procedures using Detour system
The appointment of a former Medtronic executive as CFO of ForSight Robotics brings valuable industry experience and expertise to the company’s leadership team. Fast Five hosts Sean Whooley and Danielle Kirsh discuss who was appointed and why the company decided to appoint them.
Philips’ enrollment of the first patients in a stroke diagnosis and treatment trial showcases the company’s commitment to advancing stroke care and improving patient outcomes through clinical research. Listen to today’s episode to find out what the trial will evaluate and what executives think about the trial.
Drug delivery technology developer Eitan Medical announced this week that it appointed Shaul Sharoni as its new chief financial officer. Whooley goes over Sharoni’s career background and how his appointment will contribute to the company’s growth and long-term success.
The successful completion of the first procedures using Endologix’s Detour system marks a significant milestone in the company’s U.S. launch, offering a promising treatment option for patients with vascular conditions. Kirsh and Whooley detail the technology, where the rollout began and how optimistic executives are about the first procedures.
Medtronic’s recent Class I recall affects certain implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). Find out which brands are affected and if there have been any reported incidents so far.
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Apple Podcasts
Spotify
Google + other platforms
SoundCloud
Listen to previous episodes here.
Related: Click here to sign up for our daily e-newsletter to get all the mission-critical news you need in the medical device industry straight to your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.